Antibody therapy and neuroblastoma.
Xiaohua
X
Tao
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D009447:Neuroblastoma / Q000188:drug therapy* / Q000401:mortality; D011379:Prognosis; D012107:Research Design; D015996:Survival Rate
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D007376:Interleukin-2; C112746:dinutuximab; D016178:Granulocyte-Macrophage Colony-Stimulating Factor